FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹200 Cr | ₹318 Cr | ₹221 Cr | ₹155 Cr | ₹162 Cr |
What is the latest Cash Flow from Operating Activities ratio of FDC ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹200 Cr |
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹155 Cr |
| Mar2022 | ₹162 Cr |
How is Cash Flow from Operating Activities of FDC Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹200 Cr | -36.88 | |
| Mar2025 | ₹318 Cr | 43.85 | |
| Mar2024 | ₹221 Cr | 42.51 | |
| Mar2023 | ₹155 Cr | -4.17 | |
| Mar2022 | ₹162 Cr | - | |
Compare Cash Flow from Operating Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,462.8 Cr | -1.6% | 0.1% | -26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1.6% |
0.1% |
-26.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses